Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
39,171
-0.7%
|
$8,852,646
$226.11 P/Share
|
|
Dec 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,830
-0.4%
|
$5,091,090
$223.19 P/Share
|
|
Dec 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
22,830
-0.4%
|
$5,091,090
$223.19 P/Share
|
|
Dec 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
38,960
-0.69%
|
$8,571,200
$220.5 P/Share
|
|
Dec 22
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
38,960
-0.69%
|
$8,571,200
$220.5 P/Share
|
|
Dec 21
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
18,133
-0.32%
|
$3,898,595
$215.17 P/Share
|
|
Dec 21
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
18,133
-0.32%
|
$3,898,595
$215.17 P/Share
|
|
Dec 20
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,734
-0.4%
|
$4,819,608
$212.57 P/Share
|
|
Dec 20
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
22,734
-0.4%
|
$4,819,608
$212.57 P/Share
|
|
Dec 17
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,605
-0.53%
|
$6,518,865
$213.59 P/Share
|
|
Dec 17
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
30,605
-0.53%
|
$6,518,865
$213.59 P/Share
|
|
Dec 16
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,959
-0.1%
|
$1,251,390
$210.22 P/Share
|
|
Dec 16
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
5,959
-0.1%
|
$1,251,390
$210.22 P/Share
|
|
Dec 15
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,424
-0.04%
|
$509,040
$210.28 P/Share
|
|
Dec 15
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
2,424
-0.04%
|
$509,040
$210.28 P/Share
|
|
Dec 10
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
309
-0.01%
|
$64,890
$210.2 P/Share
|
|
Dec 10
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
309
-0.01%
|
$64,890
$210.2 P/Share
|
|
Dec 09
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,994
-0.26%
|
$3,178,728
$212.13 P/Share
|
|
Dec 09
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
14,994
-0.26%
|
$3,178,728
$212.13 P/Share
|
|
Dec 08
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,871
-0.27%
|
$3,364,652
$212.89 P/Share
|
|
Dec 08
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,871
-0.27%
|
$3,364,652
$212.89 P/Share
|
|
Dec 07
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
18,520
-0.32%
|
$3,907,720
$211.78 P/Share
|
|
Dec 07
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
18,520
-0.32%
|
$3,907,720
$211.78 P/Share
|
|
Dec 03
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
400
-0.01%
|
$84,400
$211.48 P/Share
|
|
Dec 03
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
400
-0.01%
|
$84,400
$211.48 P/Share
|
|
Dec 02
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,090
-0.1%
|
$1,278,900
$210.79 P/Share
|
|
Dec 02
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
6,090
-0.1%
|
$1,278,900
$210.79 P/Share
|
|
Dec 01
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
26,642
-0.46%
|
$5,621,462
$211.57 P/Share
|
|
Dec 01
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
26,642
-0.46%
|
$5,621,462
$211.57 P/Share
|
|
Nov 30
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
197
-0.0%
|
$41,370
$210.29 P/Share
|
|
Nov 30
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
197
-0.0%
|
$41,370
$210.29 P/Share
|
|
Nov 29
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,115
-0.21%
|
$2,568,380
$212.1 P/Share
|
|
Nov 29
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
12,115
-0.21%
|
$2,568,380
$212.1 P/Share
|
|
Nov 26
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,071
-0.26%
|
$3,164,910
$210.99 P/Share
|
|
Nov 26
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,071
-0.26%
|
$3,164,910
$210.99 P/Share
|
|
Nov 24
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,578
-0.25%
|
$3,105,114
$213.26 P/Share
|
|
Nov 24
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
14,578
-0.25%
|
$3,105,114
$213.26 P/Share
|
|
Nov 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
26,057
-0.44%
|
$5,524,084
$212.64 P/Share
|
|
Nov 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
26,057
-0.44%
|
$5,524,084
$212.64 P/Share
|
|
Nov 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
48,128
-0.81%
|
$10,780,672
$224.33 P/Share
|
|
Nov 22
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
48,128
-0.81%
|
$10,780,672
$224.33 P/Share
|
|
Nov 03
2021
|
Tom C King Director |
SELL
Open market or private sale
|
Direct |
176
-22.74%
|
$39,776
$226.63 P/Share
|
|
Nov 03
2021
|
Tom C King Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+39.25%
|
$37,500
$75.63 P/Share
|
|
Nov 02
2021
|
Kevin M. Brady CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
1,250
-20.0%
|
$282,500
$226.5 P/Share
|
|
Nov 02
2021
|
Kevin M. Brady CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+16.67%
|
$112,500
$90.65 P/Share
|
|
Oct 26
2021
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$420,000
$210.0 P/Share
|
|
Oct 26
2021
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$108,000
$54.99 P/Share
|
|
Oct 26
2021
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
10,000
-61.04%
|
$2,110,000
$211.36 P/Share
|
|
Oct 26
2021
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.9%
|
$280,000
$28.32 P/Share
|
|
Oct 26
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
10,000
-41.92%
|
$2,090,000
$209.13 P/Share
|